Pharma Reaserch Prod Co Ltd (214450) — Cash Flow Quality Index
Pharma Reaserch Prod Co Ltd (214450) has a Cash Flow Quality Index of 1.89x as of December 2025. Operating cash flow of ₩61.53 Billion exceeds net income of ₩32.57 Billion, indicating high earnings quality where cash backs reported profits. Explore Pharma Reaserch Prod Co Ltd (214450) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharma Reaserch Prod Co Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Pharma Reaserch Prod Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 214450 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year earnings quality comparison for Pharma Reaserch Prod Co Ltd. For live market cap and the full company financial profile, see how much is Pharma Reaserch Prod Co Ltd worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.11x | ₩183.16 Billion | ₩165.12 Billion | ▼ -29.4% |
| 2024 | 1.57x | ₩139.88 Billion | ₩89.01 Billion | ▲ +81.9% |
| 2023 | 0.86x | ₩64.95 Billion | ₩75.18 Billion | ▼ -40.3% |
| 2022 | 1.45x | ₩59.40 Billion | ₩41.04 Billion | ▲ +3.7% |
| 2021 | 1.40x | ₩65.30 Billion | ₩46.76 Billion | ▲ +41.3% |
| 2020 | 0.99x | ₩32.39 Billion | ₩32.77 Billion | ▼ -14.5% |
| 2019 | 1.16x | ₩19.27 Billion | ₩16.67 Billion | ▲ +220.2% |
| 2018 | 0.36x | ₩5.20 Billion | ₩14.41 Billion | ▼ -45.3% |
| 2017 | 0.66x | ₩8.56 Billion | ₩12.96 Billion | ▲ +11.9% |
| 2016 | 0.59x | ₩8.16 Billion | ₩13.83 Billion | ▼ -52.6% |
| 2015 | 1.24x | ₩16.02 Billion | ₩12.88 Billion | — |